ocutx.com - Bathi sadurunge bunga, pajak, lan amortisasi OCUL

Ocular Therapeutix (OCUL) management is effectively pivoting the business toward combating macular degeneration while attracting investment. The annual EBITDA figure confirms this strategy, where 0.00 reflects the current volume of the metric. The high dedication of ophthalmology scientists ensures the quality of research. Meanwhile, unique patents for biodegradable implants and strict FDA regulations create significant barriers to entry for new players in the niche.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi Ocular Therapeutix (OCUL): kanggo periode 23.11.2025 - 15.11.2026

Ocular Pharma (OCUL) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:

Rega bursa Ocular Therapeutix, Inc.|OCUL - Target konsensus

- rincian nilai pasar emiten:

Nilai pasar Ocular Therapeutix, Inc.|OCUL - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Aset Bersih saben Saham Ocular Therapeutix|OCUL - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku ocutx.com|OCUL - Aset Agregat Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Utang marang Modal Ocular Therapeutix|OCUL - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Ocular Therapeutix|OCUL - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Ocular Therapeutix Inc|OCUL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Ocular Therapeutix|Rasio cepet ocutx.com

- rincian bathi lan kelipatan pasar:

OCUL - Bathi resik perusahaan|Penghasilan resik sing dikarepake Ocular Therapeutix|OCUL - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Ocular Therapeutix Corp|OCUL - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Ocular Therapeutix, Inc.|OCUL - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Ocular Therapeutix|OCUL - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan ocutx.com|OCUL - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Ocular Therapeutix

- data dodolan lan asil:

OCUL - Pendapatan lan volume dodolan|Prakiraan volume dodolan ocutx.com|OCUL - Rasio rega marang pendapatan|Rega mangsa ngarep marang pendapatan Ocular Therapeutix, Inc.

Pambiji fundamental perusahaan:OCUL (ocutx.com)

Produk asil prodhuksi Ocular Therapeutix Corp

This indicator measures net cash flow from core operations excluding depreciation and interest, allowing investors to see the business's real liquidity by bypassing the time lags of quarterly reporting. By analyzing actual operating profit on GURU.Markets, one can assess the resilience of Ocular Therapeutix (OCUL) to fluctuations in insurance reimbursements for implants and drops, eliminating the risk of overpaying for the asset ahead of a potential correction.

Pesaing Ocular Therapeutix (OCUL)